0001726100-22-000002.txt : 20221011 0001726100-22-000002.hdr.sgml : 20221011 20221011124930 ACCESSION NUMBER: 0001726100-22-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221011 DATE AS OF CHANGE: 20221011 EFFECTIVENESS DATE: 20221011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elysium Therapeutics, Inc. CENTRAL INDEX KEY: 0001726100 IRS NUMBER: 462769808 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-380638 FILM NUMBER: 221303372 BUSINESS ADDRESS: STREET 1: 9000 CROW CANYON ROAD, STE. 620 CITY: DANVILLE STATE: CA ZIP: 94506 BUSINESS PHONE: (925) 399-7246 MAIL ADDRESS: STREET 1: 9000 CROW CANYON ROAD, STE. 620 CITY: DANVILLE STATE: CA ZIP: 94506 D/A 1 primary_doc.xml X0708 D/A LIVE 0001726100 Elysium Therapeutics, Inc. 1201 East Market St., Suite 604 AKRON OH OHIO 44305 (925) 399-7246 DELAWARE None None Corporation true Alex Gregory Sturmer 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Executive Officer Director Thomas Jenkins 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Director Kathy LaPorte 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Director Bob Rappaport 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Director Carey Ng 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Director James Hackworth 1201 East Market Street, Suite 604 Akron OH OHIO 44305 Director Biotechnology Decline to Disclose 06b true 0001726100-20-000001 2022-09-27 false true true true false 0 9132478 2226000 6906478 false 30 0 0 0 false Elysium Therapeutics, Inc. /s/ A. Gregory Sturmer A. Gregory Sturmer President & CEO 2022-10-11